Establishment of trypsinogen-2 Amplification Luminescent Proximity Homogeneous Assay and its Application in Acute Pancreatitis
Authors:
- 5 September 2024
- journal article
- research article
- Published by Springer Nature in Journal of Fluorescence
- Vol. 35 (7) , 5355-5366
Abstract
We aim to develop an amplified luminescence proximity homogeneous assay (AlphaLISA) for quantification of trypsinogen-2 levels in human serum for the diagnosis of acute pancreatitis. Based on new amplified luminescence proximity homogeneity assay (AlphaLISA) method, carboxyl-modified donor and acceptor beads were coupled to capture and detection antibodies. A double antibody sandwich immunoassay was used to detect the concentration of trypsinogen-2 in serum. The method had good linearity (> 0.998). The intra - analysis precision was between 1.54% and 2.20% (< 10%), the inter-analysis precision was between 3.17% and 6.94% (< 15%), and the recovery was between 96.23% and 103.45%. The cross-reactivity of carbohydrate antigen 242 (CA242) and T-cell immunoglobulin mucin-3 (Tim-3) were 0.09% and 0.93%, respectively. The detection time only needed 15 min. The results of trypsinogen-2-AlphaLISA and time-resolved fluorescence immunoassay were consistent (ρ = 0.9019). In addition, serum trypsinogen-2 concentration in patients with acute pancreatitis [239.23 (17.83-807.58) ng/mL] was significantly higher than that in healthy controls [20.54 (12.10-39.73) ng/mL]. When the cut-off value was 35.38ng/mL, the sensitivity and specificity were 91.8% and 96.67%, and the positive detection rate was 91.80%. We have successfully established a trypsinogen-2-AlphaLISA method, which can promote the timely diagnosis of acute pancreatitis.Keywords
Funding Information
- The “Pioneer” and “Leading Goose” R&D Program of Zhejiang ((No. 2022C03118,2023C03075)
- The National Natural Science Foundation of China (No. 82172336)
- the Natural Science Foundation of Zhejiang Province (LQ23H050005)
- the Scientific Research Project of Zhejiang Provincial Education Department (Y202250731)
- Wuxi "Taihu talent plan" for excellent medical expert team (No. 2021-9)
This publication has 37 references indexed in Scilit:
- Biochemical markers of acute pancreatitisJournal of Clinical Pathology, 2006
- Serum level of TSGF, CA242 and CA19-9 in pancreatic cancerWorld Journal of Gastroenterology, 2004
- A Comparison of Serum Trypsinogen-2 and Trypsin-2- α 1-Antitrypsin Complex With Lipase and Amylase in The Diagnosis and Assessment of Severity in The Early Phase of Acute PancreatitisAmerican Journal of Gastroenterology, 2001
- Time Course Profile of Serum Trypsinogen-2 and Trypsin-2-a1-Antitrypsin in Patients with Acute PancreatitisScandinavian Journal of Gastroenterology, 2000
- Increased serum trypsinogen 2 and trypsin 2-α 1 antitrypsin complex values identify endoscopic retrograde cholangiopancreatography induced pancreatitis with high accuracyGut, 1997
- Serum trypsinogen-2 and trypsin-2-α1-antitrypsin complex in malignant and benign digestive-tract diseases. Preferential elevation in patients with cholangiocarcinomasInternational Journal of Cancer, 1996
- Serum Trypsinogen-2 in the Prediction of Outcome in Acute Necrotizing PancreatitisScandinavian Journal of Gastroenterology, 1996
- Time-resolved immunofluorometric assay of trypsin-2 complexed with alpha 1-antitrypsin in serumClinical Chemistry, 1994
- The clinical chemistry laboratory and acute pancreatitisClinical Chemistry, 1993
- Immunoreactive anionic and cationic trypsin in human serumClinica Chimica Acta, 1989